Pharmathen
Who owns Pharmathen?
Pharmathen is a Greek Pharma company, currently owned by Partners Group since 2021. It changed hands in 2021, when BC Partners sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods
BC Partners sold Pharmathen to Partners Group in 2021 after 6 years.
More from Partners Group Direct Equity IV
Other portfolio companies in the same fund.
US
PortugalMore PE-backed in Pharma
Comparable pharma deals from other GPs.
France
SpainQuestions
Who owns Pharmathen?
Pharmathen is currently owned by Partners Group, through Partners Group Direct Equity IV, since 2021.
When did Partners Group acquire Pharmathen?
Partners Group acquired Pharmathen in 2021.
Who did Pharmathen sell to?
BC Partners sold Pharmathen to Partners Group in 2021 (Trade Sale).
Who has owned Pharmathen over time?
Pharmathen has been through 2 private-equity ownership periods: BC Partners · via BC European Capital IX · 2015–2021 · sold to Partners Group · (Trade Sale); Partners Group · via Partners Group Direct Equity IV · since 2021.